Markers of Atrial Cardiopathay

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05623969

Enrollment

Registered

2022-11-21

Start date

2022-11-30

Completion date

2025-11-01

Last updated

2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Cardiopathy

Brief summary

Marker of atrial cardiopathay as apredictor value of ischemic stroke

Detailed description

detection of the presence of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with a one-year follow-up for any cardioembolic events (stroke /TIA).

Interventions

DIAGNOSTIC_TESTHolter ,Echo , Speckle tracking echocardiography

A 24-h ambulatory Holter Echocardiography Speckle tracking echocardiography (STE)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

17 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients complaining of palpitation referred for Holter monitoring

Exclusion criteria

* • Valvular AF, moderate to severe mitral/ tricuspid/ aortic stenosis or regurgitation. * Recent myocardial infarction within 3 months. * Acute pulmonary embolism. * Newly onset AF during or shortly after cardiac surgery. * Specific type of cardiomyopathy such as cardiac amyloidosis, obstructive hypertrophic cardiomyopathy. Decompensation stage of organ failure

Design outcomes

Primary

Measure	Time frame	Description
Detection of any underlying arrythmia after holter monitoring for twenty four hours	Detection of any underlying arrythmia after holter monitoring for twenty four hours	Detection of any underlying arrythmia after holter monitoring for twenty four hours

Secondary

Measure	Time frame	Description
Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).	Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).	Detection of atrial dysfunction or atrial cardiopathy and its degree among patients complaining of palpitation, with 6 month follow-up for any cardioembolic events (stroke /TIA).

Countries

Egypt

Contacts

Primary ContactMariam zarief farhan, resident

mariamzarif134@gmail.com01009427245

Backup ContactAmr Ahmed Aly Youssef, professor

amryoussef111@aun_edu.eg01027355511

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026